Inova Diagnostics said it has received the CE Mark for its Aptiva and Aptiva Celiac Disease Immunoglobulin A (IgA) and Immunoglobulin G (IgG) assays for diagnosing autoimmune diseases. Aptiva is based on the company's particle-based multianalyte technology (PMAT).
Inova's Aptiva automated digital multianalyte system. Image courtesy of Inova Diagnostics.Inova's PMAT technology processes multiple analytes simultaneously from a patient sample, according to the company. The platform features a 150-sample rack capacity and a 6.5-hour consumable walkaway time. It also provides up to 720 results per hour using a 12-analyte test cartridge, Inova said.
